SAN DIEGO, April 3, 2018 — Medical Marijuana, Inc.(OTC:MJNA), the first publicly traded cannabis company in the United States, today announced that it garnered news coverage on leading stock website The Motley Fool.
A Mar. 31, 2018, article on The Motley Fool’s website entitled “Say What? This GOP Senator Wants to Legalize Hemp” analyzes Mitch McConnell’s recent announcement of the Hemp Farming Act of 2018 and his previous legislative work that steered hemp into the 2014 Farm Bill.
The article states that “Should industrial hemp get the all-clear from the federal government, the only potential publicly traded winner looks to be Medical Marijuana Inc., which markets and distributes hemp oil-based products, as well as researches cannabinoid-based pharmaceuticals.”
Medical Marijuana, Inc. currently produces its full spectrum cannabidiol (CBD) hemp oil, Real Scientific Hemp Oil™, from industrial hemp grown in Europe. If made into law, the Hemp Farming Act of 2018 would not only generate a major market opportunity for U.S. farmers to potentially source CBD oil for such products from U.S.-based hemp crops, but it could make hemp cultivation legal federally as well.
The article continues stating, “Given that hemp contains considerably higher cannabidiol content relative to the cannabis plant — cannabidiol, or CBD, is the non-psychoactive component known for its medical benefits — paving the way for industrial hemp and continued research could allow Medical Marijuana Inc.’s business in the U.S. to build momentum.”
“We are thrilled that investors are recognizing how significant this yet-to-be-introduced bill would be for the Company,” said Medical Marijuana, Inc. CEO Dr. Titus. “If made into law, this new hemp legislation would give us exponential opportunities for growth and our flagship product, Real Scientific Hemp Oil, could become a more widespread standard for CBD hemp oil across the nation.”
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer CMW Media